Therefore, neutrophil elastase inhibitors have been reported to improve the prognosis of ARDS associated with sever sepsis [45] and are also recommended for management of ARDS with coagulopathy caused by COVID-19 [46]. The gene discussed is ELANE; the disease is Sepsis.